X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3935) 3935
tumor suppressor protein p53 - metabolism (2222) 2222
proto-oncogene proteins c-mdm2 - metabolism (1850) 1850
p53 (1819) 1819
proto-oncogene proteins c-mdm2 - genetics (1805) 1805
animals (1744) 1744
mdm2 (1718) 1718
tumor suppressor protein p53 - genetics (1694) 1694
proto-oncogene proteins c-mdm2 (1473) 1473
oncology (1439) 1439
cell biology (1282) 1282
female (1264) 1264
mice (1236) 1236
biochemistry & molecular biology (1159) 1159
apoptosis (1140) 1140
nuclear proteins (1104) 1104
cancer (1050) 1050
male (1044) 1044
cell line, tumor (968) 968
proto-oncogene proteins - genetics (965) 965
proto-oncogene proteins - metabolism (897) 897
expression (857) 857
middle aged (726) 726
protein (721) 721
mutation (718) 718
tumor proteins (649) 649
proteins (618) 618
adult (595) 595
aged (560) 560
activation (557) 557
phosphorylation (541) 541
research (530) 530
gene (508) 508
genetics & heredity (492) 492
protein binding (492) 492
dna-damage (488) 488
gene expression (472) 472
cell cycle (463) 463
p53 protein (462) 462
dna damage (457) 457
genetic aspects (457) 457
cell line (455) 455
gene expression regulation, neoplastic (455) 455
tumors (452) 452
nuclear proteins - metabolism (449) 449
signal transduction (446) 446
degradation (439) 439
proto-oncogene proteins c-mdm2 - antagonists & inhibitors (431) 431
immunohistochemistry (427) 427
tumor cells, cultured (423) 423
ubiquitination (414) 414
nuclear proteins - genetics (408) 408
apoptosis - drug effects (406) 406
transfection (402) 402
mdm2 protein (393) 393
pathway (393) 393
genes, p53 (384) 384
in-vivo (364) 364
gene amplification (348) 348
pathology (339) 339
wild-type p53 (339) 339
molecular sequence data (333) 333
prognosis (318) 318
neoplasms (313) 313
mutations (303) 303
polymorphism, single nucleotide (302) 302
analysis (300) 300
antineoplastic agents - pharmacology (300) 300
cell proliferation (298) 298
amplification (294) 294
cells (294) 294
embryonic lethality (294) 294
tumor suppressor protein p53 - physiology (284) 284
blotting, western (283) 283
transcriptional activation (281) 281
physiological aspects (277) 277
aged, 80 and over (276) 276
multidisciplinary sciences (272) 272
cyclin-dependent kinase inhibitor p21 (270) 270
research article (270) 270
neoplasm proteins - genetics (262) 262
health aspects (260) 260
amino acid sequence (258) 258
biology (258) 258
transcription, genetic (255) 255
binding (254) 254
mdm2-deficient mice (252) 252
tumor suppressor protein p53 - chemistry (250) 250
tumor suppressor genes (249) 249
risk factors (247) 247
cells, cultured (246) 246
piperazines - pharmacology (246) 246
tumor-suppressor (241) 241
genotype (239) 239
imidazoles - pharmacology (238) 238
neoplasms - genetics (238) 238
genes (237) 237
inhibition (237) 237
apoptosis - genetics (229) 229
gene expression regulation (228) 228
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4454) 4454
Chinese (46) 46
Japanese (18) 18
French (16) 16
German (9) 9
Russian (6) 6
Portuguese (5) 5
Polish (3) 3
Norwegian (2) 2
Spanish (2) 2
Czech (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer treatment reviews, ISSN 0305-7372, 2014, Volume 40, Issue 10, pp. 1153 - 1160
Journal Article
Nature chemical biology, ISSN 1552-4469, 2014, Volume 10, Issue 12, pp. 1000 - 1002
Journal Article
Annual review of biochemistry, ISSN 0066-4154, 6/2016, Volume 85, Issue 1, pp. 375 - 404
Inactivation of the transcription factor p53, through either direct mutation or aberrations in one of its many regulatory pathways, is a hallmark of virtually... 
cancer therapy | signaling pathways | protein evolution | drug design | p53 family | small-molecule stabilizers | Protein evolution | Signaling pathways | Drug design | Small-molecule stabilizers | P53 family | Cancer therapy | DNA-BINDING DOMAIN | TRANSIENT PROTEIN STATES | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-CYCLE ARREST | TUMOR-SUPPRESSOR P53 | CORE-DOMAIN | STRUCTURAL BASIS | SMALL-MOLECULE INHIBITORS | MUTANT P53 | TETRAMERIZATION DOMAIN | TRANSACTIVATION DOMAIN | Neoplasms - metabolism | Proto-Oncogene Proteins c-mdm2 - genetics | Antineoplastic Agents, Alkylating - chemical synthesis | Humans | Protein Multimerization | Gene Expression Regulation, Neoplastic | Proto-Oncogene Proteins - chemistry | Molecular Targeted Therapy | Proto-Oncogene Proteins c-mdm2 - chemistry | Tumor Suppressor Protein p53 - genetics | Neoplasms - genetics | Tumor Suppressor Protein p53 - agonists | Drug Design | Nuclear Proteins - genetics | Proto-Oncogene Proteins c-mdm2 - antagonists & inhibitors | Proto-Oncogene Proteins c-mdm2 - metabolism | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Protein Structure, Secondary | Signal Transduction | Tumor Suppressor Protein p53 - metabolism | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Clinical Trials as Topic | Nuclear Proteins - chemistry | Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Animals | Nuclear Proteins - antagonists & inhibitors | Molecular Docking Simulation | Tumor Suppressor Protein p53 - chemistry | Mutation | Neoplasms - pathology | Transcription factors | Care and treatment | Health aspects | Methods | Cancer
Journal Article